Neuro Startup Makes Debut With $20.9M From Novo, Johnson & Johnson Post author:Sam Post published:February 8, 2018 Post category:BioPharma Syndesi will work to modulate the synaptic vesicle protein SV2A. Source: BioSpace You Might Also Like Allergan Snaps Up Sydney Biotech for Upfront Payment of US $95M February 8, 2018 Akonni Biosystems Release: Company Strengthens Leadership Team With Multiple Key Appointments January 24, 2017 Lonza Group Announces The Successful Results Of The Rights Offering May 10, 2017
Akonni Biosystems Release: Company Strengthens Leadership Team With Multiple Key Appointments January 24, 2017
